These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


307 related items for PubMed ID: 9786965

  • 61. alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release.
    Kaiser S, Wonnacott S.
    Mol Pharmacol; 2000 Aug; 58(2):312-8. PubMed ID: 10908298
    [Abstract] [Full Text] [Related]

  • 62. The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
    Smith AM, Dhawan GK, Zhang Z, Siripurapu KB, Crooks PA, Dwoskin LP.
    Biochem Pharmacol; 2009 Oct 01; 78(7):889-97. PubMed ID: 19631612
    [Abstract] [Full Text] [Related]

  • 63. Nicotinic receptor subtypes in rat subfornical organ neurons and glial cells.
    Ono K, Toyono T, Inenaga K.
    Neuroscience; 2008 Jun 26; 154(3):994-1001. PubMed ID: 18495354
    [Abstract] [Full Text] [Related]

  • 64. α3* Nicotinic Acetylcholine Receptors in the Habenula-Interpeduncular Nucleus Circuit Regulate Nicotine Intake.
    Elayouby KS, Ishikawa M, Dukes AJ, Smith ACW, Lu Q, Fowler CD, Kenny PJ.
    J Neurosci; 2021 Feb 24; 41(8):1779-1787. PubMed ID: 33380469
    [Abstract] [Full Text] [Related]

  • 65. Atypical alpha-conotoxin LtIA from Conus litteratus targets a novel microsite of the alpha3beta2 nicotinic receptor.
    Luo S, Akondi KB, Zhangsun D, Wu Y, Zhu X, Hu Y, Christensen S, Dowell C, Daly NL, Craik DJ, Wang CI, Lewis RJ, Alewood PF, Michael McIntosh J.
    J Biol Chem; 2010 Apr 16; 285(16):12355-66. PubMed ID: 20145249
    [Abstract] [Full Text] [Related]

  • 66. Expression of α3β2β4 nicotinic acetylcholine receptors by rat adrenal chromaffin cells determined using novel conopeptide antagonists.
    Hone AJ, Rueda-Ruzafa L, Gordon TJ, Gajewiak J, Christensen S, Dyhring T, Albillos A, McIntosh JM.
    J Neurochem; 2020 Jul 16; 154(2):158-176. PubMed ID: 31967330
    [Abstract] [Full Text] [Related]

  • 67. Characterization of nicotinic receptors inducing noradrenaline release and absence of nicotinic autoreceptors in human neocortex.
    Amtage F, Neughebauer B, McIntosh JM, Freiman T, Zentner J, Feuerstein TJ, Jackisch R.
    Brain Res Bull; 2004 Feb 01; 62(5):413-23. PubMed ID: 15168907
    [Abstract] [Full Text] [Related]

  • 68. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
    Whiteaker P, Christensen S, Yoshikami D, Dowell C, Watkins M, Gulyas J, Rivier J, Olivera BM, McIntosh JM.
    Biochemistry; 2007 Jun 05; 46(22):6628-38. PubMed ID: 17497892
    [Abstract] [Full Text] [Related]

  • 69. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
    Xiao Y, Meyer EL, Thompson JM, Surin A, Wroblewski J, Kellar KJ.
    Mol Pharmacol; 1998 Aug 05; 54(2):322-33. PubMed ID: 9687574
    [Abstract] [Full Text] [Related]

  • 70. Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus.
    Cao YJ, Surowy CS, Puttfarcken PS.
    J Pharmacol Exp Ther; 2005 Mar 05; 312(3):1298-304. PubMed ID: 15542623
    [Abstract] [Full Text] [Related]

  • 71. Differential targeting of nicotinic acetylcholine receptors by novel alphaA-conotoxins.
    Jacobsen R, Yoshikami D, Ellison M, Martinez J, Gray WR, Cartier GE, Shon KJ, Groebe DR, Abramson SN, Olivera BM, McIntosh JM.
    J Biol Chem; 1997 Sep 05; 272(36):22531-7. PubMed ID: 9278406
    [Abstract] [Full Text] [Related]

  • 72. Modulation of recombinant, α2*, α3* or α4*-nicotinic acetylcholine receptor (nAChR) function by nAChR β3 subunits.
    Dash B, Bhakta M, Chang Y, Lukas RJ.
    J Neurochem; 2012 May 05; 121(3):349-61. PubMed ID: 22309577
    [Abstract] [Full Text] [Related]

  • 73. Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors.
    Grinevich VP, Papke RL, Lippiello PM, Bencherif M.
    Neuropharmacology; 2009 Aug 05; 57(2):183-91. PubMed ID: 19481556
    [Abstract] [Full Text] [Related]

  • 74. N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.
    Dwoskin LP, Wooters TE, Sumithran SP, Siripurapu KB, Joyce BM, Lockman PR, Manda VK, Ayers JT, Zhang Z, Deaciuc AG, McIntosh JM, Crooks PA, Bardo MT.
    J Pharmacol Exp Ther; 2008 Aug 05; 326(2):563-76. PubMed ID: 18460644
    [Abstract] [Full Text] [Related]

  • 75. Globular and ribbon isomers of Conus geographus α-conotoxins antagonize human nicotinic acetylcholine receptors.
    Tae HS, Gao B, Jin AH, Alewood PF, Adams DJ.
    Biochem Pharmacol; 2021 Aug 05; 190():114638. PubMed ID: 34062129
    [Abstract] [Full Text] [Related]

  • 76. Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors.
    van Hout M, Klein J, Ahring PK, Brown DT, Thaneshwaran S, Dos Santos AB, Jensen AA, Kohlmeier KA, Christophersen P, Dyhring T.
    Biochem Pharmacol; 2020 Apr 05; 174():113788. PubMed ID: 31887290
    [Abstract] [Full Text] [Related]

  • 77. Efficient binding of 4/7 α-conotoxins to nicotinic α4β2 receptors is prevented by Arg185 and Pro195 in the α4 subunit.
    Beissner M, Dutertre S, Schemm R, Danker T, Sporning A, Grubmüller H, Nicke A.
    Mol Pharmacol; 2012 Oct 05; 82(4):711-8. PubMed ID: 22802270
    [Abstract] [Full Text] [Related]

  • 78. Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties.
    Stokes C, Papke RL.
    Neuropharmacology; 2012 Sep 05; 63(4):538-46. PubMed ID: 22580377
    [Abstract] [Full Text] [Related]

  • 79. Differential block of nicotinic synapses on B versus C neurones in sympathetic ganglia of frog by alpha-conotoxins MII and ImI.
    Tavazoie SF, Tavazoie MF, McIntosh JM, Olivera BM, Yoshikami D.
    Br J Pharmacol; 1997 Mar 05; 120(6):995-1000. PubMed ID: 9134208
    [Abstract] [Full Text] [Related]

  • 80. α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo.
    McCallum SE, Cowe MA, Lewis SW, Glick SD.
    Neuropharmacology; 2012 Sep 05; 63(3):434-40. PubMed ID: 22561751
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.